Neurotech International Limited (ASX:NTI)

CTI BioPharma Revenue

Neurotech International had revenue of 113.72K AUD in the half year ending December 31, 2024, a decrease of -90.53%. This brings the company's revenue in the last twelve months to 80.48K, down -97.49% year-over-year. In the fiscal year ending June 30, 2024, Neurotech International had annual revenue of 3.18M with 166.00% growth.

• Revenue (ttm): 80.48K
• Revenue Growth: -97.49%
• P/S Ratio: 208.68
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 16.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	3.18M	1.98M	166.00%
Jun 30, 2023	1.19M	586.87K	96.59%
Jun 30, 2022	607.62K	401.25K	194.44%
Jun 30, 2021	206.37K	126.03K	156.86%
Jun 30, 2020	80.34K	-165.49K	-67.32%